Endometrial Cancer Archives - Medical Conferences

Benefit of pembrolizumab in dMMR, newly diagnosed, high-risk endometrial cancer

Presented By

Dr Toon van Gorp, UZ Leuven, Belgium

Trial

Phase 3, KEYNOTE-B21

Conference

ESMO 2024

Type

Peer-reviewed article

4 November 2024 11:22

SIENDO: Efficacy benefit of selinexor in TP53 wildtype endometrial cancer

Presented By

Dr Vicky Makker, Memorial Sloan Kettering Cancer Center, NY, USA

Trial

Phase 3, SIENDO

Conference

ASCO 2024

Type

Peer-reviewed article

18 July 2024 13:32

Novel regimen for HR-positive endometrial cancer on the way?

Presented By

Dr Angela Green, Memorial Sloan Kettering Cancer Center, NY, USA

Trial

Phase 2

Conference

ASCO 2024

Type

Peer-reviewed article

18 July 2024 13:30

Neoadjuvant immune checkpoint blockade safe and effective in MMRd endometrial cancer

Presented By

Dr Marco de Bruyn , University Medical Center Groningen, the Netherlands

Trial

Phase 1, PAM

Conference

ESMO 2023

Type

Peer-reviewed article

19 December 2023 12:34

Pembrolizumab has durable effect in previously treated MSI-H/dMMR advanced endometrial cancer

Presented By

Prof. David O’Malley, Ohio State University, USA

Trial

Phase 2, KEYNOTE-158

Conference

ESMO 2021

Type

Peer-reviewed article

19 November 2021 09:23

Palbociclib effective in ER-positive endometrial cancer

Conference

ESMO 2020

Type

Peer-reviewed article

25 November 2020 14:23